{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:12:07Z","timestamp":1773202327545,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.psyneuen.2021.105392","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T07:54:05Z","timestamp":1629273245000},"page":"105392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia: A longitudinal follow-up"],"prefix":"10.1016","volume":"133","author":[{"given":"Dongmei","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daliang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihong","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psyneuen.2021.105392_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jnr.10440","article-title":"Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs","volume":"71","author":"Bai","year":"2003","journal-title":"J. Neurosci. Res."},{"issue":"12","key":"10.1016\/j.psyneuen.2021.105392_bib2","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1017\/S0033291719001685","article-title":"Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis","volume":"49","author":"Bora","year":"2019","journal-title":"Psychol. Med."},{"issue":"22\u201323","key":"10.1016\/j.psyneuen.2021.105392_bib3","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/S0024-3205(01)01041-4","article-title":"Investigations into the physiological role of muscarinic M2 and M4 muscarinic and M4 receptor subtypes using receptor knockout mice","volume":"68","author":"Bymaster","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.psyneuen.2021.105392_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbi.2020.04.039","article-title":"Altered peripheral blood compounds in drug-na\u00efve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis","volume":"88","author":"\u00c7akici","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.psyneuen.2021.105392_bib5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1017\/S0033291721000155","article-title":"Changes in peripheral blood compounds following psychopharmacological treatment in drug-na\u00efve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis","volume":"51","author":"\u00c7akici","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psyneuen.2021.105392_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-3-642-45106-5_17","article-title":"Neurotrophins and psychiatric disorders","volume":"220","author":"Castr\u00e9n","year":"2014","journal-title":"Handb. Exp. Pharm."},{"issue":"Pt B","key":"10.1016\/j.psyneuen.2021.105392_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2016.07.010","article-title":"Brain-derived neurotrophic factor in mood disorders and antidepressant treatments","volume":"97","author":"Castr\u00e9n","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.psyneuen.2021.105392_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11530010-000000000-00000","article-title":"Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment","volume":"24","author":"Castr\u00e9n","year":"2010","journal-title":"CNS Drugs"},{"issue":"20","key":"10.1016\/j.psyneuen.2021.105392_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207777","article-title":"Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer","volume":"21","author":"Colucci-D\u2032Amato","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psyneuen.2021.105392_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.schres.2017.06.029","article-title":"Prevalence, demographic and clinical features of comorbid depressive symptoms in drug na\u00efve patients with schizophrenia presenting with first episode psychosis","volume":"193","author":"Dai","year":"2018","journal-title":"Schizophr. Res."},{"issue":"5874","key":"10.1016\/j.psyneuen.2021.105392_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1126\/science.1152677","article-title":"A model for neuronal competition during development","volume":"320","author":"Deppmann","year":"2008","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.psyneuen.2021.105392_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.1997.01830190015002","article-title":"A molecular and cellular theory of depression","volume":"54","author":"Duman","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.psyneuen.2021.105392_bib13","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.2337\/dc08-0175","article-title":"Depression: an important comorbidity with metabolic syndrome in a general population","volume":"31","author":"Dunbar","year":"2008","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.psyneuen.2021.105392_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.psyneuen.2021.105392_bib15","article-title":"Comorbid major depressive disorder in schizophrenia: a systematic review and meta-analysis","author":"Etchecopar-Etchart","year":"2020","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.psyneuen.2021.105392_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2011.09.022","article-title":"The role of BDNF in the pathophysiology and treatment of schizophrenia","volume":"46","author":"Favalli","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.psyneuen.2021.105392_bib17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1055\/s-0037-1613072","article-title":"Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation","volume":"87","author":"Fujimura","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.psyneuen.2021.105392_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.psyneuen.2021.105392_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105392_bib20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jpsychires.2018.04.014","article-title":"Suicidal ideation and behavior in US veterans with schizophrenia or bipolar disorder","volume":"102","author":"Harvey","year":"2018","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.psyneuen.2021.105392_bib21","first-page":"3071","article-title":"Effects of olanzapine on cytokine profile and brain-derived neurotrophic factor in drug-naive subjects with first-episode psychosis","volume":"17","author":"Hatziagelaki","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.psyneuen.2021.105392_bib22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0092-8674(00)81509-3","article-title":"BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex","volume":"98","author":"Huang","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.psyneuen.2021.105392_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2019.02.007","article-title":"Effect of lurasidone vs olanzapine on neurotrophic biomarkers in unmedicated schizophrenia: a randomized controlled trial","volume":"112","author":"Jena","year":"2019","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.psyneuen.2021.105392_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"14","key":"10.1016\/j.psyneuen.2021.105392_bib25","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s00213-017-4616-7","article-title":"Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis","volume":"234","author":"Kishi","year":"2017","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.psyneuen.2021.105392_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S1461145710000738","article-title":"Blood BDNF concentrations reflect brain-tissue BDNF levels across species","volume":"14","author":"Klein","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2021.105392_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.psyneuen.2019.01.029","article-title":"Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neurons","volume":"104","author":"Kowalchuk","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.psyneuen.2021.105392_bib28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.12740\/PP\/37705","article-title":"BDNF as a biomarker in the course and treatment of schizophrenia","volume":"49","author":"Libman-Soko\u0142owska","year":"2015","journal-title":"Psychiatr. Pol."},{"issue":"5","key":"10.1016\/j.psyneuen.2021.105392_bib29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.npp.1300157","article-title":"Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine","volume":"28","author":"Lieberman","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2021.105392_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109803","article-title":"m-Trifluoromethyl-diphenyl diselenide (m-CF(3)-PhSe)(2) modulates the hippocampal neurotoxic adaptations and abolishes a depressive-like phenotype in a short-term morphine withdrawal in mice","volume":"98","author":"Martins","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.psyneuen.2021.105392_bib31","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.psyneuen.2021.105392_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/00207454.2018.1527328","article-title":"Direct and indirect evidences of BDNF and NGF as key modulators in depression: role of antidepressants treatment","volume":"129","author":"Mondal","year":"2019","journal-title":"Int. J. Neurosci."},{"issue":"3","key":"10.1016\/j.psyneuen.2021.105392_bib33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/acps.12374","article-title":"Second-generation antipsychotic effect on cognition in patients with schizophrenia--a meta-analysis of randomized clinical trials","volume":"131","author":"Nielsen","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.psyneuen.2021.105392_bib34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.cmet.2017.06.005","article-title":"Modulation of autophagy by BDNF underlies synaptic plasticity","volume":"26","author":"Nikoletopoulou","year":"2017","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.psyneuen.2021.105392_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.pharep.2013.12.008","article-title":"The influence of aripiprazole, olanzapine and enriched environment on depressant-like behavior, spatial memory dysfunction and hippocampal level of BDNF in prenatally stressed rats","volume":"66","author":"Nowakowska","year":"2014","journal-title":"Pharm. Rep."},{"issue":"2","key":"10.1016\/j.psyneuen.2021.105392_bib36","first-page":"237","article-title":"BDNF function and intracellular signaling in neurons","volume":"25","author":"Numakawa","year":"2010","journal-title":"Histol. Histopathol."},{"issue":"3","key":"10.1016\/j.psyneuen.2021.105392_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/104012371602800305","article-title":"Longitudinal assessment of clinical risk factors for depression in schizophrenia spectrum disorders","volume":"28","author":"Onwuameze","year":"2016","journal-title":"Ann. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.psyneuen.2021.105392_bib38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S146114570500564X","article-title":"Effects of chronic administration of olanzapine, amitriptyline, haloperidol or sodium valproate in naive and anhedonic rats","volume":"9","author":"Orsetti","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.psyneuen.2021.105392_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neulet.2003.10.079","article-title":"Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol","volume":"356","author":"Parikh","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.psyneuen.2021.105392_bib40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/syn.21634","article-title":"Effects of antipsychotic drugs on the expression of synaptic proteins and dendritic outgrowth in hippocampal neuronal cultures","volume":"67","author":"Park","year":"2013","journal-title":"Synapse"},{"issue":"9680","key":"10.1016\/j.psyneuen.2021.105392_bib41","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(09)60660-7","article-title":"Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001\u201305: an epidemiological survey","volume":"373","author":"Phillips","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.psyneuen.2021.105392_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neubiorev.2017.10.001","article-title":"On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: a systematic review","volume":"83","author":"Pinto","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psyneuen.2021.105392_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172853","article-title":"Chronic oral treatment with risperidone impairs recognition memory and alters brain-derived neurotrophic factor and related signaling molecules in rats","volume":"189","author":"Poddar","year":"2020","journal-title":"Pharm. Biochem. Behav."},{"key":"10.1016\/j.psyneuen.2021.105392_bib44","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis","volume":"174","author":"Polyakova","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2021.105392_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.etap.2016.07.007","article-title":"The influence of aripiprazole and olanzapine on neurotransmitters level in frontal cortex of prenatally stressed rats","volume":"46","author":"Ratajczak","year":"2016","journal-title":"Environ. Toxicol. Pharm."},{"issue":"2","key":"10.1016\/j.psyneuen.2021.105392_bib46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hup.1101","article-title":"Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone","volume":"25","author":"Riedel","year":"2010","journal-title":"Hum. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psyneuen.2021.105392_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000315438","article-title":"Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia","volume":"62","author":"Rizos","year":"2010","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psyneuen.2021.105392_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpsychires.2018.09.007","article-title":"The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: a meta-analysis","volume":"106","author":"Rodrigues-Amorim","year":"2018","journal-title":"J. Psychiatr. Res."},{"issue":"11","key":"10.1016\/j.psyneuen.2021.105392_bib49","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0006-3223(98)00093-6","article-title":"A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia","volume":"43","author":"Tollefson","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105392_bib50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2019.05.006","article-title":"Co-treatment of buspirone with atypical antipsychotic drugs (AAPDs) improved neurocognitive function in chronic schizophrenia","volume":"209","author":"Wang","year":"2019","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.psyneuen.2021.105392_bib51","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1177\/070674370304801102","article-title":"Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24\u2009h of treatment","volume":"48","author":"Wright","year":"2003","journal-title":"Can. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.psyneuen.2021.105392_bib52","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0149-2918(03)80129-7","article-title":"A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy","volume":"25","author":"Wright","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.psyneuen.2021.105392_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104879","article-title":"BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: a prospective 12-week longitudinal study","volume":"122","author":"Wu","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2021.105392_bib54","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/schbul\/sbaa062","article-title":"Interrelationships between BDNF, superoxide dismutase, and cognitive impairment in drug-naive first-episode patients with schizophrenia","volume":"46","author":"Xiu","year":"2020","journal-title":"Schizophr. Bull."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453021002663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453021002663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:14:03Z","timestamp":1759684443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453021002663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":54,"alternative-id":["S0306453021002663"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105392","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia: A longitudinal follow-up","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105392"}}